Report Detail
Global Ophthalmic Drugs Market Research Report 2019
- RnM3108106 |
- 12 March, 2019 |
- Global |
- 100 Pages |
- QYResearch |
- Pharma & Healthcare
Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.
According to the American Academy of Ophthalmology over 27.1 million of North American population is suffering from Primary Open Angle Glaucoma (POAG) and this number is constantly rising. Thus, increasing eye disorders is fueling the growth of the global ophthalmic drugs market.
It was reported that around two-third of the population in the Asia Pacific region are blind or vision impaired. Moreover, development of various novel technologies in developing markets such as China & India is expected to improve healthcare facilities.
The global Ophthalmic Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ophthalmic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ophthalmic Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Santen Pharmaceutical
Valeant Pharmaceuticals
Shire
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
Segment by Regions
North America
Europe
China
Japan
Segment by Type
By Class
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
By Disease
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Segment by Application
Hospital
Clinic
Pharmacy
Table of Contents
Executive Summary
1 Ophthalmic Drugs Market Overview
- 1.1 Product Overview and Scope of Ophthalmic Drugs
- 1.2 Ophthalmic Drugs Segment By Class
- 1.2.1 Global Ophthalmic Drugs Production Growth Rate Comparison By Class (2014-2025)
- 1.2.2 Anti-allergy
- 1.2.3 Anti-VEGF Agents
- 1.2.4 Anti-inflammatory
- 1.2.5 Anti-glaucoma
- 1.3 Ophthalmic Drugs Segment by Application
- 1.3.1 Ophthalmic Drugs Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Pharmacy
- 1.4 Global Ophthalmic Drugs Market by Region
- 1.4.1 Global Ophthalmic Drugs Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Ophthalmic Drugs Market Size
- 1.5.1 Global Ophthalmic Drugs Revenue (2014-2025)
- 1.5.2 Global Ophthalmic Drugs Production (2014-2025)
2 Global Ophthalmic Drugs Market Competition by Manufacturers
- 2.1 Global Ophthalmic Drugs Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Ophthalmic Drugs Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Ophthalmic Drugs Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Ophthalmic Drugs Production Sites, Area Served, Product Types
- 2.5 Ophthalmic Drugs Market Competitive Situation and Trends
- 2.5.1 Ophthalmic Drugs Market Concentration Rate
- 2.5.2 Ophthalmic Drugs Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Ophthalmic Drugs Production Market Share by Regions
- 3.1 Global Ophthalmic Drugs Production Market Share by Regions
- 3.2 Global Ophthalmic Drugs Revenue Market Share by Regions (2014-2019)
- 3.3 Global Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Ophthalmic Drugs Production
- 3.4.1 North America Ophthalmic Drugs Production Growth Rate (2014-2019)
- 3.4.2 North America Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Ophthalmic Drugs Production
- 3.5.1 Europe Ophthalmic Drugs Production Growth Rate (2014-2019)
- 3.5.2 Europe Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Ophthalmic Drugs Production (2014-2019)
- 3.6.1 China Ophthalmic Drugs Production Growth Rate (2014-2019)
- 3.6.2 China Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Ophthalmic Drugs Production (2014-2019)
- 3.7.1 Japan Ophthalmic Drugs Production Growth Rate (2014-2019)
- 3.7.2 Japan Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Ophthalmic Drugs Consumption by Regions
- 4.1 Global Ophthalmic Drugs Consumption by Regions
- 4.2 North America Ophthalmic Drugs Consumption (2014-2019)
- 4.3 Europe Ophthalmic Drugs Consumption (2014-2019)
- 4.4 China Ophthalmic Drugs Consumption (2014-2019)
- 4.5 Japan Ophthalmic Drugs Consumption (2014-2019)
5 Global Ophthalmic Drugs Production, Revenue, Price Trend by Type
- 5.1 Global Ophthalmic Drugs Production Market Share by Type (2014-2019)
- 5.2 Global Ophthalmic Drugs Revenue Market Share by Type (2014-2019)
- 5.3 Global Ophthalmic Drugs Price by Type (2014-2019)
- 5.4 Global Ophthalmic Drugs Production Growth by Type (2014-2019)
6 Global Ophthalmic Drugs Market Analysis by Applications
- 6.1 Global Ophthalmic Drugs Consumption Market Share by Application (2014-2019)
- 6.2 Global Ophthalmic Drugs Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Ophthalmic Drugs Business
- 7.1 Santen Pharmaceutical
- 7.1.1 Santen Pharmaceutical Ophthalmic Drugs Production Sites and Area Served
- 7.1.2 Ophthalmic Drugs Product Introduction, Application and Specification
- 7.1.3 Santen Pharmaceutical Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Valeant Pharmaceuticals
- 7.2.1 Valeant Pharmaceuticals Ophthalmic Drugs Production Sites and Area Served
- 7.2.2 Ophthalmic Drugs Product Introduction, Application and Specification
- 7.2.3 Valeant Pharmaceuticals Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Shire
- 7.3.1 Shire Ophthalmic Drugs Production Sites and Area Served
- 7.3.2 Ophthalmic Drugs Product Introduction, Application and Specification
- 7.3.3 Shire Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Novartis
- 7.4.1 Novartis Ophthalmic Drugs Production Sites and Area Served
- 7.4.2 Ophthalmic Drugs Product Introduction, Application and Specification
- 7.4.3 Novartis Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Genentech
- 7.5.1 Genentech Ophthalmic Drugs Production Sites and Area Served
- 7.5.2 Ophthalmic Drugs Product Introduction, Application and Specification
- 7.5.3 Genentech Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Allergan
- 7.6.1 Allergan Ophthalmic Drugs Production Sites and Area Served
- 7.6.2 Ophthalmic Drugs Product Introduction, Application and Specification
- 7.6.3 Allergan Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Sun Pharmaceutical Industries
- 7.7.1 Sun Pharmaceutical Industries Ophthalmic Drugs Production Sites and Area Served
- 7.7.2 Ophthalmic Drugs Product Introduction, Application and Specification
- 7.7.3 Sun Pharmaceutical Industries Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Actavis Generics
- 7.8.1 Actavis Generics Ophthalmic Drugs Production Sites and Area Served
- 7.8.2 Ophthalmic Drugs Product Introduction, Application and Specification
- 7.8.3 Actavis Generics Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Regeneron Pharmaceuticals
- 7.9.1 Regeneron Pharmaceuticals Ophthalmic Drugs Production Sites and Area Served
- 7.9.2 Ophthalmic Drugs Product Introduction, Application and Specification
- 7.9.3 Regeneron Pharmaceuticals Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Pfizer
- 7.10.1 Pfizer Ophthalmic Drugs Production Sites and Area Served
- 7.10.2 Ophthalmic Drugs Product Introduction, Application and Specification
- 7.10.3 Pfizer Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 Johnson and Johnson
- 7.12 Bausch and Lomb
8 Ophthalmic Drugs Manufacturing Cost Analysis
- 8.1 Ophthalmic Drugs Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Ophthalmic Drugs
- 8.4 Ophthalmic Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Ophthalmic Drugs Distributors List
- 9.3 Ophthalmic Drugs Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Ophthalmic Drugs Market Forecast
- 11.1 Global Ophthalmic Drugs Production, Revenue Forecast
- 11.1.1 Global Ophthalmic Drugs Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Ophthalmic Drugs Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Ophthalmic Drugs Price and Trend Forecast (2019-2025)
- 11.2 Global Ophthalmic Drugs Production Forecast by Regions (2019-2025)
- 11.2.1 North America Ophthalmic Drugs Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Ophthalmic Drugs Production, Revenue Forecast (2019-2025)
- 11.2.3 China Ophthalmic Drugs Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Ophthalmic Drugs Production, Revenue Forecast (2019-2025)
- 11.3 Global Ophthalmic Drugs Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Ophthalmic Drugs Consumption Forecast (2019-2025)
- 11.3.2 Europe Ophthalmic Drugs Consumption Forecast (2019-2025)
- 11.3.3 China Ophthalmic Drugs Consumption Forecast (2019-2025)
- 11.3.4 Japan Ophthalmic Drugs Consumption Forecast (2019-2025)
- 11.4 Global Ophthalmic Drugs Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Ophthalmic Drugs Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Ophthalmic Drugs. Industry analysis & Market Report on Ophthalmic Drugs is a syndicated market report, published as Global Ophthalmic Drugs Market Research Report 2019. It is complete Research Study and Industry Analysis of Ophthalmic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
